Implications of CHA2DS2-VASc Score in Stroke Patients with Atrial Fibrillation: An Analysis of 938 Korean Patients

Volume and morphology of left atrial appendage as determinants of stroke subtype in patients with atrial fibrillation

(2016) Woo Kyo Jeong et al.   HEART RHYTHM

Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants

(2016) Oh Young Bang et al.   Journal of Stroke

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial

(2015) Christian T Ruff et al.   LANCET

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   CIRCULATION

Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong

(2014) Chung-Wah Siu et al.   HEART RHYTHM

Eligibility and Preference of New Oral Anticoagulants in Patients With Atrial Fibrillation

(2014) Chang Hyo Yoon et al.   STROKE

New Oral Anticoagulants May Be Particularly Useful for Asian Stroke Patients

(2014) Oh Young Bang et al.   Journal of Stroke

Is Atrial Fibrillation Always a Culprit of Stroke in Patients with Atrial Fibrillation plus Stroke?

(2013) Suk Jae Kim et al.   CEREBROVASCULAR DISEASES

Safety and Efficacy of Adjusted Dose of Rivaroxaban in Japanese Patients With Non-Valvular Atrial Fibrillation

(2013) Masatsugu Hori et al.   CIRCULATION JOURNAL

Epidemiology of stroke and its subtypes in Chinese vs white populations: A systematic review

(2013) C.-F. Tsai et al.   NEUROLOGY

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2DS2-VASc scores

(2011) M.-J. Cha et al.   EUROPEAN JOURNAL OF NEUROLOGY

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increases in Cerebral Atherosclerosis According to CHADS 2 Scores in Patients With Stroke With Nonvalvular Atrial Fibrillation

(2011) Young Dae Kim et al.   STROKE

Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting

(2011) John Eikelboom et al.   THROMBOSIS AND HAEMOSTASIS

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Evidence That D-Dimer Levels Predict Subsequent Thromboembolic and Cardiovascular Events in Patients With Atrial Fibrillation During Oral Anticoagulant Therapy

(2010) Tsuneaki Sadanaga et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antithrombotic Drug Use, Cerebral Microbleeds, and Intracerebral Hemorrhage

(2010) Caroline E. Lovelock et al.   STROKE

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: Data from a diverse race-ethnic group

(2009) Oh Young Bang et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Cerebral microbleeds: a guide to detection and interpretation

(2009) Steven M Greenberg et al.   LANCET NEUROLOGY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

(2009) G. Y. H. Lip et al.   THROMBOSIS AND HAEMOSTASIS

Tissue Doppler index, E/E', and ischemic stroke in patients with atrial fibrillation and preserved left ventricular ejection fraction

(2008) Sang-Hak Lee et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES